Stay updated on Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThis update appears to be a visual redesign of the page header and footer with no changes to the study record content or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedUpdated status notice and version to v3.2.0, replacing v3.1.0; added information about government funding lapse and operating status, and where to find details.SummaryDifference13%

- Check46 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check60 days agoChange DetectedOnly the revision tag changed from v3.0.1 to v3.0.2; no substantive content changes.SummaryDifference0.3%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%

- Check74 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related details have been removed.SummaryDifference4%

Stay in the know with updates to Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.